Corvus Pharmaceuticals, Inc. Lease, Cost
Corvus Pharmaceuticals, Inc. (CRVS) reported Lease, Cost of $185.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-06
- Corvus Pharmaceuticals, Inc. lease, cost for the quarter ending 2026-06-30 was $185.00K, a 11.45% increase year-over-year.
- Corvus Pharmaceuticals, Inc. lease, cost for the quarter ending 2026-03-31 was $291.00K, a 115.56% increase year-over-year.
- Corvus Pharmaceuticals, Inc. lease, cost for the quarter ending 2025-09-30 was $228.00K, a 45.71% decline year-over-year.
- Corvus Pharmaceuticals, Inc. lease, cost for the quarter ending 2025-06-30 was $166.00K, a 60.57% decline year-over-year.
- Corvus Pharmaceuticals, Inc. lease, cost for fiscal 2023 was $1.64M, a 17.26% increase from fiscal 2022.
- Corvus Pharmaceuticals, Inc. lease, cost for fiscal 2022 was $1.40M, a 2.77% decline from fiscal 2021.
- Corvus Pharmaceuticals, Inc. lease, cost for fiscal 2021 was $1.44M, a 10.24% increase from fiscal 2020.
- Corvus Pharmaceuticals, Inc. lease, cost for fiscal 2020 was $1.31M, a 1.87% increase from fiscal 2019.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $185.00K 10-Q · filed 2026-08-06 | $359.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $291.00K 10-Q · filed 2026-05-07 | |||
| 2025-09-30 | $228.00K 10-Q · filed 2025-11-04 | $394.00K derived: sum of 2 quarters · filed 2026-08-06 | $529.00K 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $166.00K 10-Q · filed 2026-08-06 | $301.00K 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $135.00K 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $420.00K 10-Q · filed 2024-11-12 | $841.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.28M 10-Q · filed 2024-11-12 | $1.70M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $421.00K 10-Q · filed 2024-08-06 | $857.00K 10-Q · filed 2024-08-06 | $1.27M derived: sum of 3 quarters · filed 2024-08-06 | $1.69M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $436.00K 10-Q · filed 2024-05-07 | $854.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.27M derived: sum of 3 quarters · filed 2024-11-12 | $1.66M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $836.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.23M derived: sum of 3 quarters · filed 2024-11-12 | $1.64M 10-K · filed 2024-03-19 |
| 2023-09-30 | $418.00K 10-Q · filed 2024-11-12 | $809.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.23M 10-Q · filed 2024-11-12 | $1.64M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $391.00K 10-Q · filed 2024-08-06 | $808.00K 10-Q · filed 2024-08-06 | $1.22M derived: sum of 3 quarters · filed 2024-08-06 | $1.64M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $417.00K 10-Q · filed 2024-05-07 | $832.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.25M derived: sum of 3 quarters · filed 2024-05-07 | $1.41M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $829.00K derived: sum of 2 quarters · filed 2024-03-19 | $988.00K derived: sum of 3 quarters · filed 2024-03-19 | $1.40M 10-K · filed 2024-03-19 |
| 2022-09-30 | $414.00K 10-Q · filed 2023-11-07 | $573.00K derived: sum of 2 quarters · filed 2023-11-07 | $987.00K 10-Q · filed 2023-11-07 | $1.39M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $159.00K 10-Q · filed 2023-08-08 | $573.00K 10-Q · filed 2023-08-08 | $977.00K derived: sum of 3 quarters · filed 2024-03-19 | $1.34M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | $414.00K 10-Q · filed 2023-05-08 | $818.00K derived: sum of 2 quarters · filed 2024-03-19 | $1.18M derived: sum of 3 quarters · filed 2024-03-19 | $1.51M derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $404.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $763.00K derived: sum of 2 quarters · filed 2024-03-19 | $1.10M derived: sum of 3 quarters · filed 2024-03-19 | $1.44M 10-K · filed 2024-03-19 |
| 2021-09-30 | $359.00K 10-Q · filed 2022-11-03 | $696.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.04M 10-Q · filed 2022-11-03 | $1.36M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $337.00K 10-Q · filed 2022-08-08 | $678.00K 10-Q · filed 2022-08-08 | $1.00M derived: sum of 3 quarters · filed 2023-03-28 | $1.33M derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $341.00K 10-Q · filed 2022-05-05 | $668.00K derived: sum of 2 quarters · filed 2023-03-28 | $994.00K derived: sum of 3 quarters · filed 2023-03-28 | $1.32M derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $653.00K derived: sum of 2 quarters · filed 2023-03-28 | $979.00K derived: sum of 3 quarters · filed 2023-03-28 | $1.31M 10-K · filed 2023-03-28 |
| 2020-09-30 | $326.00K 10-Q · filed 2021-11-01 | $652.00K derived: sum of 2 quarters · filed 2021-11-01 | $981.00K 10-Q · filed 2021-11-01 | $1.30M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $326.00K 10-Q · filed 2021-08-02 | $653.00K 10-Q · filed 2021-08-02 | $974.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.29M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $327.00K 10-Q · filed 2021-04-29 | $648.00K derived: sum of 2 quarters · filed 2022-03-10 | $968.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.28M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $641.00K derived: sum of 2 quarters · filed 2022-03-10 | $955.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.28M 10-K · filed 2022-03-10 |
| 2019-09-30 | $320.00K 10-Q · filed 2020-10-29 | $634.00K derived: sum of 2 quarters · filed 2020-10-29 | $963.00K 10-Q · filed 2020-10-29 | $1.27M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $314.00K 10-Q · filed 2020-07-30 | $643.00K 10-Q · filed 2020-07-30 | $955.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.19M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-03-31 | $330.00K 10-Q · filed 2020-04-30 | $641.00K derived: sum of 2 quarters · filed 2021-03-25 | $880.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.12M derived: sum of 4 quarters · filed 2021-03-25 |
| 2018-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $550.00K derived: sum of 2 quarters · filed 2021-03-25 | $790.00K derived: sum of 3 quarters · filed 2021-03-25 | $1.04M 10-K · filed 2021-03-25 |
| 2018-09-30 | $239.00K 10-Q · filed 2019-10-29 | $479.00K derived: sum of 2 quarters · filed 2019-10-29 | $733.00K 10-Q · filed 2019-10-29 | |
| 2018-06-30 | $240.00K 10-Q · filed 2019-08-01 | $493.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $252.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $1.01M 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |